Systemic Proteome Profiling to Differentiate Primary Glomerular Diseases
Journal of the American Society of Nephrology · 2026
DOI: 10.1681/asn.0000001054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026. Verfasst von Jae-Ik Oh und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Seoul National University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Proteomics, Nephrosis, Lipoid, Proteome, Glomerulonephritis, IGA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Health and Welfare, National Research Foundation of Korea.
Abstract (Originalsprache)
Key Points Plasma proteome profiling identified distinct signatures across biopsy-proven primary glomerular disease subtypes. An elastic net model using 93 proteins classified primary glomerular disease subtypes and controls, with external validation. Integrating proteomics with machine learning yields biologically interpretable insights in primary glomerular diseases.
Background
Primary GN is a heterogeneous group of kidney disorders where understanding of their pathophysiology remains incomplete. Despite the diagnostic potential of high-throughput proteomics, constrained proteomic depth and a reliance on binary comparisons have left the feasibility of using systemic signatures to differentiate multiple GN subtypes largely unexplored.
Methods
To identify protein signatures that noninvasively differentiate major primary glomerular disease subtypes and provide mechanistic insights, we performed large-scale systemic proteome profiling of 5416 plasma proteins via Olink Explore HT in a discovery cohort ( n =147) and an external validation cohort ( n =85) of Korean participants (mean age, 41±13 years; 46% female). The study population included patients with four GN subtypes—focal segmental glomerulosclerosis, IgA nephropathy, minimal change disease, and membranous nephropathy—alongside healthy controls. We developed a machine learning (ML) model using logistic regression with elastic net regularization to classify disease groups based on proteomic profiles and evaluated its performance in the independent validation cohort.
Results
Plasma proteome profiles were distinct among disease subtypes, emerging as a significant source of data variation independent of conventional markers such as eGFR or proteinuria levels. The ML model performed robustly in both the discovery and validation cohorts, achieving an area under the receiver operating characteristic curve >0.8 for differentiating minimal change disease, membranous nephropathy, and IgA nephropathy. The model, even without clinical information, correctly identified 93% of minimal change disease cases (14 of 15) and 63% of IgA nephropathy cases (20 of 32), but its performance was limited for focal segmental glomerulosclerosis, with only 21% of cases (three of 14) correctly classified. Functional analysis of key proteins highlighted distinct biologic pathways, such as hemostasis in minimal change disease.
Conclusions
We identified distinct systemic proteome signatures for primary glomerular diseases, where disease subtype served as a major determinant of proteomic variance alongside conventional clinical markers. ML models demonstrated robust discriminatory performance for minimal change disease, membranous nephropathy, and IgA nephropathy, underscoring the potential for proteome-based classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
- Department of Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, South Korea.
- Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
- Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong-si, South Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
ORCID-Profile: Jae-Ik Oh, Kyeonghun Jeong, Jung Hun Koh, Jin Kyung Kwon, Semin Cho, Yaerim Kim, Hajeong Lee, Hyun Je Kim, Jung Pyo Lee, Ji In Park, Jung Tak Park, Kwangsoo Kim, Sehoon Park, Dong Ki Kim
Förderung
- Ministry of Health and Welfare
- National Research Foundation of Korea
Zitieren
APA
Oh, J. I., Jeong, K., Koh, J. H., Kwon, J. K., Cho, S., Cho, J. M., Kim, Y., Lee, H., Kim, H. J., Lee, J., Lee, J. P., Park, J. I., Park, J. T., Kim, K., Park, S., Kim, D. K., & KORNERSTONE Investigators (2026). Systemic Proteome Profiling to Differentiate Primary Glomerular Diseases. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001054
Vancouver
Oh JI, Jeong K, Koh JH, Kwon JK, Cho S, Cho JM, et al. Systemic Proteome Profiling to Differentiate Primary Glomerular Diseases. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001054
BibTeX
@article{Oh2026,
author = {Oh, Jae-Ik and Jeong, Kyeonghun and Koh, Jung Hun and Kwon, Jin Kyung and Cho, Semin and Cho, Jeong Min and Kim, Yaerim and Lee, Hajeong and Kim, Hyun Je and Lee, Jeonghwan and Lee, Jung Pyo and Park, Ji In and Park, Jung Tak and Kim, Kwangsoo and Park, Sehoon and Kim, Dong Ki and KORNERSTONE Investigators, KORNERSTONE Investigators},
title = {Systemic Proteome Profiling to Differentiate Primary Glomerular Diseases},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000001054}
}
EUVIMED